U.S. Markets open in 1 hr, 35 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,451.19 | -128.00 | -1.49% |
| NASDAQ | 1,649.51 | 4.39 | 0.27% |
| S&P 500 | 899.22 | -10.70 | -1.18% |
| Day Low 01:12 PM EDT | 12.62 | |
|---|---|---|
| Day High 10:10 AM EDT | 14.55 |
|
| Range | 1.93 | |
| Volume | 271,391 | |
| 30-Day Avg. Vol. | 179,000 |
|
| Difference | 51.62% | |
| Market Cap. | 302.22 M | |
| Change | -40.88 M | |
| Shares Out. | 23.22 M | |
| Percent Traded | 1.17% | |
| Revenue (LFY) | 22 M | |
| Earnings (TTM) | -5.06 M | |
| Next Earnings |
|
|
| EPS (TTM) | -1.95 |
| 52-Wk Low 10/22/07 | 11.96 | |
|---|---|---|
| 52-Wk High 1/17/08 | 36.44 |
|
| Range | 24.48 | |
| Prev. Close 10/9/08 | 14.77 | |
| Today's Open | 14.44 | |
| Change | -2.23% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | — | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -6.00 |
Pharmasset uses its intellectual capital to take down the viruses that take down people's defenses. The company develops and plans to commercialize oral anti-viral drugs based on its nucleoside analog ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.442 3/31/08 | -0.57 3/31/08 |
-0.128
Missed
|
| Last Quarter | -0.611 6/30/08 | -0.69 6/30/08 |
-0.079
Missed
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 464,291.00 | 22.01 M |
| Gross Profit | 213,727.00 | 21.12 M |
| Operating Income | -14.51 M | -7.52 M |
| Net Income | -15.03 M | -5.06 M |
